AIMAIM ImmunoTech Inc.
Partial data—Mkt Cap: —P/E: —109d ago
AIM ImmunoTech Inc., an immuno-pharma company, engages in the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company…
Industry Peers
HealthcareKey Statistics
Company
Market Cap—
Enterprise Value3.98M $
Revenue (TTM)94.00K $
Gross Profit-40.00K $
Net Income (TTM)-13.96M $
Revenue/Share0.0370 USD
Last Price—
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees19
CountryUS
SectorHealthcare
Industry—
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.72
PEG0.71
EV/EBITDA-0.40
EV/Revenue42.37
P/S110.31
P/B-0.12
EPS (TTM)-4.31
EPS (Forward)-0.52
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin-45.45%
Oper. Margin-10118.18%
EBITDA Margin0.00%
Profit Margin-15861.36%
ROE142.68%
ROA-241.40%
Growth
Revenue Growth37.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.96M $
CapEx (TTM)378.00K $
FCF Margin-13005.72%
FCF Yield—
Net Debt-1.30M $
Net Debt/EBITDA0.13
Balance Sheet
Debt/Equity-0.50
Current Ratio1.01
Quick Ratio0.96
Book Value/Sh-3.1870 USD
Cash/Share0.4040 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1031:1000
Split DateFeb 10, 2026
Analyst Consensus
Rating—
Target (Mean)5.250 USD
Target Range1.500 USD – 9.000 USD
# Analysts2
Ownership
Shares Out.27.72M
Float12.01M
Insiders0.60%
Institutions0.78%
Short Interest
Short Ratio0.1d
Short % Float29.00%
Short % Out.28.83%
Shares Short7.01M
Short (prev mo.)303.17K
Technical
SMA 500.4574 USD
SMA 2001.243 USD
Beta1.17
S&P 52W Chg20.90%
Avg Vol (30d)—
Avg Vol (10d)6.49M
Technical Indicators
RSI (14)46.2
MACD0.0040
MACD Signal0.0113
MACD Hist.-0.0073
BB Upper0.8331 USD
BB Middle0.4540 USD
BB Lower0.0749 USD
BB Width167.01%
ATR (14)0.1479 USD
Vol Ratio (20d)0.02x